Literature DB >> 15730383

Targeting the dendritic cell: the key to immunotherapy in cancer?

A Faith, C M Hawrylowicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15730383      PMCID： PMC1809304          DOI： 10.1111/j.1365-2249.2005.02737.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  31 in total

1.  Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy.

Authors:  R Thomas; M Chambers; R Boytar; K Barker; L L Cavanagh; S MacFadyen; M Smithers; M Jenkins; J Andersen
Journal:  Melanoma Res       Date:  1999-10       Impact factor: 3.599

2.  Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction.

Authors:  P L Vieira; E C de Jong; E A Wierenga; M L Kapsenberg; P Kaliński
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

Review 3.  Active immunization against cancer with dendritic cells: the near future.

Authors:  R M Steinman; M Dhodapkar
Journal:  Int J Cancer       Date:  2001-11       Impact factor: 7.396

Review 4.  Roles of heat-shock proteins in innate and adaptive immunity.

Authors:  Pramod Srivastava
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

Review 5.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 6.  Manipulating dendritic cell biology for the active immunotherapy of cancer.

Authors:  David W O'Neill; Sylvia Adams; Nina Bhardwaj
Journal:  Blood       Date:  2004-07-01       Impact factor: 22.113

7.  A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

Authors:  H Jonuleit; A Giesecke-Tuettenberg; T Tüting; B Thurner-Schuler; T B Stuge; L Paragnik; A Kandemir; P P Lee; G Schuler; J Knop; A H Enk
Journal:  Int J Cancer       Date:  2001-07-15       Impact factor: 7.396

8.  Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes.

Authors:  Steven A Rosenberg; Mark E Dudley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

Review 9.  Cancer immunotherapy: a treatment for the masses.

Authors:  Joseph N Blattman; Philip D Greenberg
Journal:  Science       Date:  2004-07-09       Impact factor: 47.728

10.  Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.

Authors:  Alain P Vicari; Claudia Chiodoni; Céline Vaure; Smina Aït-Yahia; Christophe Dercamp; Fabien Matsos; Olivier Reynard; Catherine Taverne; Philippe Merle; Mario P Colombo; Anne O'Garra; Giorgio Trinchieri; Christophe Caux
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307
View more
  1 in total

Review 1.  Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy.

Authors:  Seokhwan Chung; Richard A Revia; Miqin Zhang
Journal:  Nanoscale Horiz       Date:  2021-07-20       Impact factor: 11.684
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.